Let's Get Started!

Thank you for considering Hanson Wade Intelligence

We’re genuinely excited to hear that you’re on the lookout for a market research partner. At Hanson Wade Intelligence, we’re not just partners; we’re collaborators, innovators, and explorers in the extensive world of drug landscape insights.

Step Into a World of Tailored Solutions!

Your projects and goals are unique, and so should be the market research partnership you engage in. To align our expertise with your aspirations, we invite you to share a bit more about your project. The form below is your pathway to bespoke solutions tailored to your project, goals, and timelines.

Your Dedicated Guide: Sam Sarwar

Once we’ve had a chance to peruse your details, Sam Sarwar from our Customer Success Team will be reaching out to delve deeper into your project requirements and explore how we can navigate towards your desired outcomes together. Await an email from Sam and, to ensure our communications sail smoothly to your inbox, please anchor ‘@hansonwade.com’ to your safe sender list.

Insights, Straight to Your Harbor

As we gear up to set sail together, we won’t leave you adrift. Continue to receive the freshest insights and updates from the drug landscape right in your inbox, helping you stay abreast of the currents in the industry.

Access the Sales Brochure now for more information on how we can help to empower your scientific and strategic decision making.

Client case study

Due Diligence of Early-Stage Cell Therapy Asset

Market landscape and competitive assessment to inform an asset purchase decision for a large biotech company.

Our client was facing a short deadline to make a decision whether to in-license a pre-clinical cell therapy asset with a novel mechanism of action. This was a large and dynamic market with considerable competitive pressure, as well as complex and unclear commercial and regulatory considerations.

Our client needed a granular understanding of the current market situation as well as market potential in specific indications of interest. A review of the competitive drug landscape as well as forecasts for the drug treatable patient pool and commercial potential would support validation of the asset and inform a go/no-go decision on the acquisition.


We assessed the entire landscape and identified a number of key competitive programs that represent a potential threat to the asset of interest.

Our holistic evaluation of these highly relevant programs allowed our client to determine the extent and quality of competition in the space, clearly highlighting the relative benefits and limitations of the technology under evaluation.

Our assessment of the market potential of the technology, in the context of the competitive and scientific assessment, provided a comprehensive body of evidence that allowed the deal team to make a final decision on the asset purchase with clarity and confidence.

The team did an excellent job. Through both the landscaping insights and the interviews directly with our prospects we obtained a deeper understanding of how we should be approaching the market.
BSP Pharmaceuticals
Hanson Wade were fantastic to work with! James and the team were very collaborative throughout and helped us hone in on some really precise market insights that will inform our ongoing product strategy. The qualitative interviews with biopharma KOLs in particular, have given us a deeper appreciation of the challenges and opportunities in the custom assay development.
Senior Director, Strategic Marketing, Cell Signaling Technology